hsa-miR-125b

ncRNA information

ncRNA name

hsa-miR-125b

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

Bcl-2

Cancer information

Cancer name

Nasopharyngeal Carcinoma

Cancer site

Nasopharynx

Treatment information

Treatment type

Chemotherapy

Drug

5-Fluorouracil/Cisplatin/Etoposide/Vincristine

Impact of wild-type ncRNA on chemotherapy resistance

Down

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

The results suggest that miR-125b may regulate the sensitivity of NPC cells to DDP by modulating the expression levels of antiapoptotic factor B-cell CLL/lymphoma 2.

Tissue resource

human nasopharyngeal carcinoma cell lines CNE2

Experiment

qRT-PCR,Western blot


Institute

Sun Yat-Sen University Cancer Center

Country

China

Continent

Asia